LMF Acquisition Opportunities

Yahoo Finance • 13 days ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Data show results consistent with clinical trial experience A high level of safety – no device-related adverse events Strong survival data extending to 90 days DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporati... Full story

Yahoo Finance • 18 days ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Independent DSMB reports zero device-related safety issues Supports potential clinical benefit Trial sample size re-estimated to strengthen statistical power DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation... Full story

Yahoo Finance • 19 days ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance Registry will be presented by SeaSta... Full story

Yahoo Finance • last month

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

DENVER, Sept. 04, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • last month

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

DENVER, Sept. 02, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • 2 months ago

SeaStar Medical Holding GAAP EPS of -$0.18 beats by $0.25, revenue of $0.34M beats by $0.14M

* SeaStar Medical Holding press release [https://seekingalpha.com/pr/20200176-seastar-medical-reports-second-quarter-2025-financial-results-and-provides-business-updates] (NASDAQ:ICU [https://seekingalpha.com/symbol/ICU]): Q2 GAAP EPS of... Full story

Yahoo Finance • 2 months ago

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Business highlights include: Adult NEUTRALIZE-AKI trial enrolls 31 new patients, now over 60% enrolledThree new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI)Positive survival re... Full story

Yahoo Finance • 2 months ago

SeaStar Medical files to sell 10.92M shares of common stock for holders

* SeaStar Medical (NASDAQ:ICU [https://seekingalpha.com/symbol/ICU]) filed to sell 10.92M shares of common stock for holders. * This preliminary prospectus is not an offer to sell. * Filing [https://seekingalpha.com/filing/10286537]... Full story

Yahoo Finance • 2 months ago

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

DENVER, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • 2 months ago

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Trial now over 60% enrolled with 125 of 200 anticipated patients Recent new site activation brings total clinical trial sites to 16 Interim analysis of first 100 patients remains on track for 3Q 2025 DENVER, Aug. 06, 2025 (GLOBE NEWSW... Full story

Yahoo Finance • 3 months ago

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive preliminary results from the SAVE Surveillance Registry which is assessing the u... Full story

Yahoo Finance • 3 months ago

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Highest Rated Children’s Medical Centers Now Employ QUELIMMUNE for Ultra-Rare Cases of Pediatric AKI HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance DENVER, July 16, 2025 (GLOBE NEWSWIR... Full story

Yahoo Finance • 3 months ago

SeaStar Medical Announces $4 Mln Direct Offering With Warrants In Concurrent Private Placement

(RTTNews) - SeaStar Medical Holding Corporation (ICU), a healthcare company focused on treating critical organ failure, has entered into a definitive agreement for a registered direct offering of 5,242,464 shares of its common stock or equ... Full story

Yahoo Finance • 3 months ago

SeaStar Medical raises $4 million in at-market offering

DENVER - SeaStar Medical Holding Corporation (NASDAQ:ICU), a micro-cap healthcare company with a market capitalization of $11.3 million, announced Thursday it has entered into a definitive agreement to raise approximately $4 million throug... Full story

Yahoo Finance • 3 months ago

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • 3 months ago

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

DENVER, July 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • 3 months ago

SeaStar Medical shareholders approve director elections and equity plan changes

SeaStar Medical Holding Corp (NASDAQ:ICU) reported Tuesday that shareholders approved all proposals presented at the company’s annual meeting, held virtually on July 3. According to a press release statement and SEC filing, shareholders e... Full story

Yahoo Finance • 3 months ago

Medical Holding Corporation regains Nasdaq compliance

DENVER - Medical Holding Corporation (NASDAQ:ICU), a micro-cap healthcare company with a market capitalization of approximately $9 million, has regained compliance with Nasdaq’s minimum stockholders’ equity requirement of $2.5 million, the... Full story

Yahoo Finance • 3 months ago

SeaStar Medical announces positive Nasdaq listing determination

* SeaStar Medical Holding Corporation (NASDAQ:ICU [https://seekingalpha.com/symbol/ICU]) said on Wednesday that it has received [https://seekingalpha.com/pr/20155464-seastar-medical-announces-positive-nasdaq-listing-determination] confir... Full story

Yahoo Finance • 3 months ago

SeaStar Medical Announces Positive Nasdaq Listing Determination

DENVER, July 02, 2025 (GLOBE NEWSWIRE) -- Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, an... Full story